Turing to cut pricing for Daraprim amid backlash
The company's decision to hike the drug's price by more than 5,500 percent was the subject of a recent New York Times story. In a phone call with NBC News, Turing's Martin Shkreli said he will cut the cost of treatment in response to the public outcry.
September 22, 2015 at 06:56PM
via Digg http://ift.tt/1L4rHC6
No comments:
Post a Comment